RLAY Relay Therapeutics, Inc.: institutional ownership and insider trading
280 funds reported holding $4.75B of Relay Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $1.21B, with 48 new positions and 30 funds selling out; over the last 12 months insiders bought $0 and sold $130M on the open market.
Famous investors holding RLAY
- Stanley Druckenmiller (Duquesne Family Office): $6.53M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $13.1M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $24.1M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $11.1M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $3.60M, 0.0% of the portfolio
Largest institutional holders of RLAY
- SB INVESTMENT ADVISERS (UK) LTD — $522M
- FMR LLC — $376M
- Casdin Capital, LLC — $300M
- BlackRock, Inc. (BLK) — $286M
- PERCEPTIVE ADVISORS LLC — $264M
- Commodore Capital LP — $225M
- STATE STREET CORP (STT, STT-PG) — $189M
- VANGUARD CAPITAL MANAGEMENT LLC — $168M
- PRICE T ROWE ASSOCIATES INC /MD/ — $144M
- Nextech Invest, Ltd. — $127M
Recent RLAY insider trades
- Oct 7, 2026: Patel Sanjiv sold 48,199 shares ($872K)
- Oct 6, 2026: Catinazzo Thomas sold 17,717 shares ($329K)
- Sep 8, 2026: Patel Sanjiv sold 48,199 shares ($913K)
- Sep 8, 2026: Catinazzo Thomas sold 17,717 shares ($336K)
5%+ owners
- FMR LLC: 10.0% (Schedule 13G/A, filed Aug 7, 2026)
- Perceptive Advisors LLC: 6.4% (Schedule 13G/A, filed Aug 10, 2026)
- Commodore Capital LP: 5.5% (Schedule 13G/A, filed Aug 14, 2026)